Hepatic resistin mRNA expression was significantly up-regulated in NASH patients compared with simple steatosis group (P < 0.05) and controls (P < 0.05) (Figure 2A). The gene discussed is RETN; the disease is metabolic dysfunction-associated steatohepatitis.